BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
53.40
-0.42 (-0.78%)
At close: Dec 5, 2025, 4:00 PM EST
53.02
-0.38 (-0.71%)
After-hours: Dec 5, 2025, 5:20 PM EST
BioMarin Pharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 10,259 | 12,527 | 18,162 | 19,234 | 16,220 | 15,918 | |
| Market Cap Growth | -13.14% | -31.03% | -5.57% | 18.57% | 1.90% | 4.81% | |
| Enterprise Value | 9,385 | 12,199 | 18,132 | 19,051 | 16,229 | 15,917 | |
| Last Close Price | 53.40 | 65.73 | 96.42 | 103.49 | 88.35 | 87.69 | |
| PE Ratio | 19.92 | 29.35 | 108.34 | 135.87 | - | 18.64 | |
| Forward PE | 11.13 | 17.86 | 38.98 | 39.00 | 85.79 | 75.56 | |
| PS Ratio | 3.30 | 4.39 | 7.51 | 9.18 | 8.79 | 8.56 | |
| PB Ratio | 1.69 | 2.21 | 3.67 | 4.18 | 3.80 | 3.88 | |
| P/TBV Ratio | 1.82 | 2.44 | 4.10 | 4.73 | 4.41 | 4.56 | |
| P/FCF Ratio | 12.33 | 25.70 | 290.28 | 350.06 | 77.63 | - | |
| P/OCF Ratio | 11.22 | 21.87 | 114.04 | 109.34 | 53.26 | 186.47 | |
| PEG Ratio | 0.58 | 0.72 | 1.07 | 0.86 | 2.66 | 1.75 | |
| EV/Sales Ratio | 3.03 | 4.28 | 7.50 | 9.09 | 8.79 | 8.56 | |
| EV/EBITDA Ratio | 11.82 | 18.30 | 62.49 | 121.62 | 481.22 | 1186.81 | |
| EV/EBIT Ratio | 13.19 | 21.40 | 97.60 | 348.42 | - | - | |
| EV/FCF Ratio | 11.28 | 25.03 | 289.80 | 346.74 | 77.67 | - | |
| Debt / Equity Ratio | 0.10 | 0.11 | 0.23 | 0.24 | 0.26 | 0.28 | |
| Debt / EBITDA Ratio | 0.75 | 0.93 | 3.73 | 6.58 | 23.56 | 43.10 | |
| Debt / FCF Ratio | 0.73 | 1.30 | 18.12 | 20.38 | 5.38 | - | |
| Asset Turnover | 0.43 | 0.41 | 0.37 | 0.34 | 0.31 | 0.35 | |
| Inventory Turnover | 0.45 | 0.50 | 0.53 | 0.60 | 1.49 | 1.67 | |
| Quick Ratio | 2.84 | 2.96 | 1.45 | 2.98 | 2.54 | 3.07 | |
| Current Ratio | 4.83 | 5.33 | 2.51 | 4.67 | 4.16 | 4.76 | |
| Return on Equity (ROE) | 9.07% | 8.05% | 3.51% | 3.19% | -1.53% | 23.63% | |
| Return on Assets (ROA) | 6.15% | 5.15% | 1.76% | 0.55% | -0.78% | -1.09% | |
| Return on Capital (ROIC) | 7.01% | 5.76% | 1.97% | 0.61% | -0.87% | -1.24% | |
| Return on Capital Employed (ROCE) | 10.40% | 8.90% | 3.30% | 0.90% | -1.40% | -1.70% | |
| Earnings Yield | 5.07% | 3.41% | 0.92% | 0.74% | -0.40% | 5.37% | |
| FCF Yield | 8.11% | 3.89% | 0.34% | 0.29% | 1.29% | -0.18% | |
| Buyback Yield / Dilution | -2.10% | -2.67% | -1.39% | -3.34% | 4.61% | -7.06% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.